Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Concerns sort of short term sort of not

<< Previous

Bullboard Posts

Next >>

Comment by MrMugsyon Dec 02, 2020 1:10pm

166 Views

Post# 32018781

RE:RE:RE:RE:RE:Concerns sort of short term sort of not

Ogre03 wrote:
better then me. Got burnt trying to play some dips lol. Average is up to .38 or 3.8 depending on how you look at it. The bought deal and that run up in aug 2019 still leaves a sour taste. Maybe I hold a grudge lol

Ya - maybe.
But you won't be holding a grudge at $7, or $8 or $10 etc.
The past will be a blur if their first drug is as good as we're thinking.
Phase 2 says we're looking good.

If FDA welcomes us to Phase 3, we just need an air tight plan to get us through it.
That plan is probably built now.

<< Previous

Bullboard Posts

Next >>

Pro Women’s Hockey League comes to NHL 25 in December